![Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio | | victoriaadvocate.com Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio | | victoriaadvocate.com](https://bloximages.newyork1.vip.townnews.com/victoriaadvocate.com/content/tncms/assets/v3/editorial/b/1d/b1d7aaaa-de98-5e21-b51b-48f2f0f0410d/63a0f08dde4ec.image.jpg?resize=1026%2C500)
Herpes treatment market to grow by 4.05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth - Technavio | | victoriaadvocate.com
![Researchers Find Evidence of Link Between Herpes Simplex (Cold Sores) and Neurodegenerative Diseases Researchers Find Evidence of Link Between Herpes Simplex (Cold Sores) and Neurodegenerative Diseases](https://scitechdaily.com/images/Cold-Sore-777x518.jpg?ezimgfmt=rs:350x233/rscb2/ngcb2/notWebP)
Researchers Find Evidence of Link Between Herpes Simplex (Cold Sores) and Neurodegenerative Diseases
![Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting | Business Wire Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting | Business Wire](https://mms.businesswire.com/media/20230223006032/en/739014/22/teva_RGB_JPEG.jpg)